Inebilizumab |
| Katalog-Nr.GC69278 |
Inebilizumab is a monoclonal antibody (mAb) against CD19, which enhances antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab is being studied for multiple sclerosis and neuromyelitis optica.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1299440-37-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Inebilizumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Inebilizumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *